RDInvesting Provides Investors with Free In-Depth Equity Reports on AYR, BNNY, FTI and RNA


Follow this company

Companies Mentioned

NYSE:AYR / NYSE:BNNY / NYSE:FTI / NASDAQ:RNA
02/12/2014 [ACCESSWIRE]

Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.

Aircastle Limited (NYSE: AYR) shares declined 3.83 percent to close at $17.82 a share Tuesday. The stock traded between $17.35 and $18.09 on volume of 1.17 million shares traded. Analysts at Morgan Stanley have recently downgraded the company’s rating to "underweight" from "equalweight". Shares of Aircastle have fallen approximately 7.0 percent year-to-date.

Find out more about Aircastle including full access to the free equity report at:        
www.RDInvesting.com/AYR

Annie’s Inc. (NYSE: BNNY) shares declined 8.65 percent to close at $38.21 a share Tuesday. The stock traded between $37.40 and $38.98 on volume of 3.03 million shares traded. Analysts at Credit Suisse have recently downgraded the company’s rating to "neutral" from "outperform". Shares of Annie’s have fallen approximately 11.0 percent year-to-date.

Find out more about Annie’s including full access to the free equity report at:     
www.RDInvesting.com/BNNY

FMC Technologies, Inc. (NYSE: FTI) shares gained 2.36 percent to close at $50.27 a share Tuesday. The stock traded between $49.52 and $50.61 on volume of 2.73 million shares traded. Analysts at Societe Generale have recently upgraded the company’s rating to "buy" from "hold". Shares of FMC Technologies have gained approximately 8.0 percent year-to-date.

Find out more about FMC Technologies including full access to the free equity report at:       
www.RDInvesting.com/FTI

Prosensa Holding NV (NASDAQ: RNA) shares spiked 9.76 percent to close at $6.52 a share Tuesday. The stock traded between $6.34 and $6.75 on volume of 804,607 shares traded. Analysts at Wedbush have recently upgraded the company’s rating to "outperform" from "neutral". Shares of Prosensa have gained approximately 40.0 percent year-to-date.

Find out more about Prosensa including full access to the free equity report at:         
www.RDInvesting.com/RNA

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.

Contact:            
Research Driven Investing               
info@rdinvesting.com

COMMENTS

Leave a comment...
 * 

Your Name
 *